NK-One Therapeutics, Inc.
CIK 2127553 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for NK-One Therapeutics, Inc..
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Apr 27, 2026 | D | 0002127553-26-000001 |